Literature DB >> 20647547

Up-regulation of hepatic lipolysis stimulated lipoprotein receptor by leptin: a potential lever for controlling lipid clearance during the postprandial phase.

Christophe Stenger1, Marine Hanse, Dagmar Pratte, Marie-Ludvine Mbala, Samina Akbar, Violette Koziel, Marie-Christine Escanyé, Badreddine Kriem, Catherine Malaplate-Armand, Jean-Luc Olivier, Thierry Oster, Thierry Pillot, Frances T Yen.   

Abstract

As a hepatic receptor for triglyceride-rich lipoproteins, the lipolysis-stimulated lipoprotein receptor (LSR) may be involved in the dynamics of lipid distribution between the liver and peripheral tissues. Here, we explore the potential role of leptin in regulating LSR. At physiological concentrations (1-10 ng/ml), leptin increased LSR protein and mRNA levels in Hepa1-6 cells through an ERK1/2-dependent and α-amanitin-sensitive pathway. In vivo, leptin treatment of C57BL6/Rj mice (1 μg 2×/d, 8 d) led to a significant increase in hepatic LSR mRNA and protein, decreased liver triglycerides and increased VLDL secretion as compared to controls. LSR(+/-) mice with elevated postprandial lipemia placed on a high-fat (60% kcal) diet exhibited accelerated weight gain and increased fat mass as compared to controls. While plasma leptin levels were increased 3-fold, hepatic leptin receptor protein levels and phosphorylation of ERK1/2 were significantly reduced. Therefore, leptin is an important regulator of LSR protein levels providing the means for the control of hepatic uptake of lipids during the postprandial phase. However, this may no longer be functional in LSR(+/-) mice placed under a chronic dietary fat load, suggesting that this animal model could be useful for the study of molecular mechanisms involved in peripheral leptin resistance.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20647547     DOI: 10.1096/fj.10-160440

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  12 in total

1.  Spontaneously diabetic Ins2(+/Akita):apoE-deficient mice exhibit exaggerated hypercholesterolemia and atherosclerosis.

Authors:  John Y Jun; Zhexi Ma; Lakshman Segar
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-03-29       Impact factor: 4.310

2.  Nuclear Localized LSR: A Novel Regulator of Breast Cancer Behavior and Tumorigenesis.

Authors:  Denise K Reaves; Katherine A Hoadley; Katerina D Fagan-Solis; Dereje D Jima; Michael Bereman; Lynnelle Thorpe; Jyla Hicks; David McDonald; Melissa A Troester; Charles M Perou; Jodie M Fleming
Journal:  Mol Cancer Res       Date:  2016-11-17       Impact factor: 5.852

3.  Leptin treatment inhibits the progression of atherosclerosis by attenuating hypercholesterolemia in type 1 diabetic Ins2(+/Akita):apoE(-/-) mice.

Authors:  John Y Jun; Zhexi Ma; Rajkumar Pyla; Lakshman Segar
Journal:  Atherosclerosis       Date:  2012-10-12       Impact factor: 5.162

4.  ILDR2: an endoplasmic reticulum resident molecule mediating hepatic lipid homeostasis.

Authors:  Kazuhisa Watanabe; Elizabeth Watson; Maria Laura Cremona; Elizabeth J Millings; Jay H Lefkowitch; Stuart G Fischer; Charles A LeDuc; Rudolph L Leibel
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

5.  Transcriptional Characterization of Porcine Leptin and Leptin Receptor Genes.

Authors:  Dafne Pérez-Montarelo; Almudena Fernández; Carmen Barragán; Jose L Noguera; Josep M Folch; M Carmen Rodríguez; Cristina Ovilo; Luis Silió; Ana I Fernández
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

6.  The role of lipolysis stimulated lipoprotein receptor in breast cancer and directing breast cancer cell behavior.

Authors:  Denise K Reaves; Katerina D Fagan-Solis; Karen Dunphy; Shannon D Oliver; David W Scott; Jodie M Fleming
Journal:  PLoS One       Date:  2014-03-17       Impact factor: 3.240

7.  Interaction of dietary fat intake with APOA2, APOA5 and LEPR polymorphisms and its relationship with obesity and dyslipidemia in young subjects.

Authors:  Teresa Domínguez-Reyes; Constanza C Astudillo-López; Lorenzo Salgado-Goytia; José F Muñoz-Valle; Aralia B Salgado-Bernabé; Iris P Guzmán-Guzmán; Natividad Castro-Alarcón; Ma E Moreno-Godínez; Isela Parra-Rojas
Journal:  Lipids Health Dis       Date:  2015-09-13       Impact factor: 3.876

8.  Inhibitory action of benzo[α]pyrene on hepatic lipoprotein receptors in vitro and on liver lipid homeostasis in mice.

Authors:  Hamed Layeghkhavidaki; Marie-Claire Lanhers; Samina Akbar; Lynn Gregory-Pauron; Thierry Oster; Nathalie Grova; Brice Appenzeller; Jordane Jasniewski; Cyril Feidt; Catherine Corbier; Frances T Yen
Journal:  PLoS One       Date:  2014-07-23       Impact factor: 3.240

9.  The roles of tricellular tight junction protein lipolysis-stimulated lipoprotein receptor in malignancy of human endometrial cancer cells.

Authors:  Hiroshi Shimada; Seiro Satohisa; Takayuki Kohno; Syunta Takahashi; Tsubasa Hatakeyama; Takumi Konno; Mitsuhiro Tsujiwaki; Tsuyoshi Saito; Takashi Kojima
Journal:  Oncotarget       Date:  2016-05-10

10.  Interaction of Clostridium perfringens Iota Toxin and Lipolysis-Stimulated Lipoprotein Receptor (LSR).

Authors:  Masahiro Nagahama; Masaya Takehara; Keiko Kobayashi
Journal:  Toxins (Basel)       Date:  2018-10-08       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.